#IAS 2023

Female medical doctor holding red heart shape in hand with graphic of heart beat, cardiology and insurance concept

Statin Cuts Cardiovascular Risk for People With HIV

POZ March 2019 cover U=U Undetectable = Untransmitable

WHO Reaffirms HIV Treatment Is Prevention

City of Geneva with Jet d'Eau fountain at sunset, Switzerland

Geneva Man May Be Cured of HIV After Wild-Type Stem Cell Transplant

Statin Cuts Cardiovascular Risk for People With HIV

WHO Reaffirms HIV Treatment Is Prevention

Geneva Man May Be Cured of HIV After Wild-Type Stem Cell Transplant

British Experts Recommend Statins for All HIV-Positive People 40 and Older

Updated guidance is based on findings from the REPRIEVE trial, which showed pitavastatin reduced the risk of cardiovascular events by 35%.

Do Weight-Loss Drugs Work for People With HIV?

In limited studies to date, semaglutide and other weight-loss drugs appear to be safe and effective for people living with HIV.

Women in Africa Prefer Long-Acting PrEP Over Pills

When given a choice, most women chose injectable cabotegravir over daily prevention pills.

HIV Unmuted - The Breaking Science From IAS 2023

We take a deep dive into the breaking science being released at IAS 2023 and explain why these breakthroughs are so important.

Vamsi Vasireddy, MD, DrPh, (second from left) received a prize for research in long-acting HIV prevention and treatment in Uganda.

Spotlight on IAS 2023

This year’s International AIDS Society (IAS) Conference on HIV Science was held over four days in Brisbane, Australia.

Do Integrase Inhibitors Raise the Risk of Cardiovascular Disease?

Certain drugs in this class may increase the likelihood of diabetes and hypertension, but cardiovascular risk factors can be managed.

Biktarvy Is Safe and Effective During Pregnancy

Drug levels remained adequate throughout pregnancy, so no dose adjustment was needed.

People With HIV Remain at Greater Risk for Death Due to COVID-19

COVID mortality declined overall during the omicron wave but less so for people with HIV.

Switching to Dolutegravir and Lamivudine Works Well Despite Resistance Mutations

Using two instead of three or four drugs could potentially lead to cost savings in the billions.

PrEP Exposure Before Birth Doesn’t Harm Children’s Bones

At three years, median height and bone mineral density were similar for children with and without tenofovir exposure in the womb.

Can an Immune-Modulating Drug Help Clear the HIV Reservoir?

Ruxolitinib might have contributed to a functional cure after a stem cell transplant without a rare mutation.

Are People With HIV at Risk for Severe Mpox?

Global study highlights the importance of prompt HIV treatment and viral suppression to prevent severe monkeypox.

Sunlenca Pills Can Bridge Gaps When Injections Are Missed

People who used once-weekly oral lenacapavir maintained viral suppression when injections were interrupted.

JIAS Publishes Special Issue on Person-Centered Care Models for People Living with HIV

Person-centered care models that serve people living with HIV and key populations remain scarce and haphazardly implemented globally.

Final IAS 2023 Conversations: HIV & STI Prevention, Stigma, and U=U

HIV.gov conversations about doxyPEP, HIV PrEP and the effectiveness of U=U.

HIV Vaccines, bNAbs and an Update from NIH’s Office of AIDS Research

NIH’s Carl Dieffenbach and Bill Kapogiannis interview experts about research presented at IAS 2023.

#IAS 2023

Statin Cuts Cardiovascular Risk for People With HIV

WHO Reaffirms HIV Treatment Is Prevention

Geneva Man May Be Cured of HIV After Wild-Type Stem Cell Transplant

Statin Cuts Cardiovascular Risk for People With HIV

WHO Reaffirms HIV Treatment Is Prevention

Geneva Man May Be Cured of HIV After Wild-Type Stem Cell Transplant

British Experts Recommend Statins for All HIV-Positive People 40 and Older

Do Weight-Loss Drugs Work for People With HIV?

Women in Africa Prefer Long-Acting PrEP Over Pills

HIV Unmuted - The Breaking Science From IAS 2023

Spotlight on IAS 2023

Do Integrase Inhibitors Raise the Risk of Cardiovascular Disease?

Biktarvy Is Safe and Effective During Pregnancy

People With HIV Remain at Greater Risk for Death Due to COVID-19

Switching to Dolutegravir and Lamivudine Works Well Despite Resistance Mutations

PrEP Exposure Before Birth Doesn’t Harm Children’s Bones

Can an Immune-Modulating Drug Help Clear the HIV Reservoir?

Are People With HIV at Risk for Severe Mpox?

Sunlenca Pills Can Bridge Gaps When Injections Are Missed

JIAS Publishes Special Issue on Person-Centered Care Models for People Living with HIV

Final IAS 2023 Conversations: HIV & STI Prevention, Stigma, and U=U

HIV Vaccines, bNAbs and an Update from NIH’s Office of AIDS Research

Features

Science News